AcquisitionOther
Cyclacel Pharmaceuticals, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Cyclacel Pharmaceuticals, Inc. -> target · $0.0001
She specializes in business development, strategic consultancy and corporate advisory in mergers and acquisition and joint venture across Malaysia, Singapore, China, Japan, Thailand and Indonesia.
Open source record (SEC) ↗